Collplant Biotechnologies Ltd ADR CLGN

$4.64 +0.68 (17.17%)

Valuation

Market cap
8,773,000
Revenue TTM
$2,370,000
Net income TTM
$-11,490,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-484.81%
Debt to equity
0.00

Trading

Volume
439,300
Avg volume
77,275
Day's range
$4.05 – $4.64
Shares out
1,891,000
Stochastic %K
100%
Beta
1.66
Analysts
Strong Buy
Price target
$110.00

Price

Company profile

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue filler...

Show more

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound care product for the treatment of deep surgical incisions and deep wounds. It also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. The company has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

Industry
Biotechnology
Sector
Healthcare
Phone
972 73 232 5600
Website
https://collplant.com
Address
Weizmann Science Park, 4 Oppenheimer P.O. Box 4132, Rehovot, Israel

Latest news

No headlines yet.

Stocktwits

QES Nov 18, 2:31 PM
$CLGN https://stkt.co/_0hYBwIy The Israel-based startup LightSolver is also targeting algorithms that are a more natural fit for its device. “If you look at propagating electromagnetic waves, essentially, they are running differential equations in their nature,” says Ruti Ben-Shlomi, CEO and cofounder of LightSolver. She says differential equations can be solved much faster and with higher energy efficiency on the company’s laser processing unit (LPU) than on a traditional computer. LightSolver’s LPU is an interesting twist on the Goodman optical-computer design. It has input light, a programmable membrane in the form of a spatial light modulator, and output light, but the whole thing is placed in a cavity, where light bounces back and forth many times before reaching a steady state. In addition, the team places a gain medium inside the cavity. This gain medium functions much like those found inside a laser, causing the bouncing light to build up in intensity. ..GO AND READ IT
0 replies
WallStWireAds Nov 18, 2:11 PM
$CLGN https://spectrum.ieee.org/optical-computing-ai?itm_source=homepage&itm_medium=hero&itm_campaign=hero-2026-11-17&itm_content=hero5
0 replies
QES Nov 18, 6:49 AM
$CLGN https://www.youtube.com/watch?v=_t3p5l5RH_g
0 replies
QES Nov 18, 6:43 AM
$CLGN uploaded three weeks ago: https://www.youtube.com/watch?v=KQMXH8iRw3Q
0 replies
QES Nov 16, 3:58 PM
$CLGN Dilution is sucking out the value per share. Current market cap is listed, elsewhere, as $11.23 Mil. Mar cap here is $6.9 mil. Price per share essentially unchanged. Share count up circa 1.6x. That means the stock price, WITHOUT dilution, would be circa $6.05. That is the issue here: we are getting diluted badly.
0 replies
Wilsonism Nov 14, 8:12 PM
$OPHI with $CLGN ticker in rear view its time to realize the potential here. New highs ahead.
0 replies
WangSLO Nov 13, 9:09 PM
$CLGN only 324 volume today ?
0 replies
WangSLO Nov 13, 7:00 PM
$CLGN is this demonstration enough to launch it to mars? $OPHI $CLGN
1 replies